In Vitro Comparative Study of Platelets Treated with Two Pathogen-Inactivation Methods to Extend Shelf Life to 7 Days

Background and Objectives: Since 2015, platelet products have been pathogen-inactivated (PI) at the Luxemburgish Red Cross (LRC) using Riboflavin and UV light (RF-PI). As the LRC should respond to hospital needs at any time, platelet production exceeds the demand, generating a discard rate of 18%. T...

Full description

Bibliographic Details
Main Authors: Nicolas Malvaux, Fanette Defraigne, Styliani Bartziali, Camille Bellora, Kathleen Mommaerts, Fay Betsou, Anne Schuhmacher
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/11/3/343
_version_ 1797443795522945024
author Nicolas Malvaux
Fanette Defraigne
Styliani Bartziali
Camille Bellora
Kathleen Mommaerts
Fay Betsou
Anne Schuhmacher
author_facet Nicolas Malvaux
Fanette Defraigne
Styliani Bartziali
Camille Bellora
Kathleen Mommaerts
Fay Betsou
Anne Schuhmacher
author_sort Nicolas Malvaux
collection DOAJ
description Background and Objectives: Since 2015, platelet products have been pathogen-inactivated (PI) at the Luxemburgish Red Cross (LRC) using Riboflavin and UV light (RF-PI). As the LRC should respond to hospital needs at any time, platelet production exceeds the demand, generating a discard rate of 18%. To reduce this, we consider the extension of storage time from 5 to 7 days. This study’s objective was to evaluate the in vitro 7-day platelet-storage quality, comparing two PI technologies, RF-PI and amotosalen/UVA light (AM-PI), for platelet pools from whole-blood donations (PPCs) and apheresis platelets collected from single apheresis donation (APCs). Materials and Methods: For each product type, 6 double-platelet concentrates were prepared and divided into 2 units; one was treated with RF-PI and the other by AM-PI. In vitro platelet-quality parameters were tested pre- and post-PI, at days 5 and 7. Results: Treatment and storage lesions were observed in PPCs and APCs with both PI methods. We found a higher rate of lactate increase and glucose depletion, suggesting a stronger stimulation of the glycolytic pathway, a higher Annexin V binding, and a loss of swirling in the RF-PI-treated units from day 5. The platelet loss was significantly higher in the AM-PI compared with the RF-PI units. Conclusions: Results suggest that RF-PI treatment has a higher deleterious impact on in vitro platelet quality compared to AM-PI, but we observed higher loss of platelets with AM-PI due to the post-illumination amotosalen adsorption step. If 7-day storage is needed, it can only be achieved with AM-PI, based on our quality criteria.
first_indexed 2024-03-09T13:03:10Z
format Article
id doaj.art-cc3ad1ecc98d4f7fada9729dca5f680f
institution Directory Open Access Journal
issn 2076-0817
language English
last_indexed 2024-03-09T13:03:10Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj.art-cc3ad1ecc98d4f7fada9729dca5f680f2023-11-30T21:52:44ZengMDPI AGPathogens2076-08172022-03-0111334310.3390/pathogens11030343In Vitro Comparative Study of Platelets Treated with Two Pathogen-Inactivation Methods to Extend Shelf Life to 7 DaysNicolas Malvaux0Fanette Defraigne1Styliani Bartziali2Camille Bellora3Kathleen Mommaerts4Fay Betsou5Anne Schuhmacher6Red Cross of Luxemburg, Boulevard Joseph II, 40, L-1840 Luxembourg, LuxembourgRed Cross of Luxemburg, Boulevard Joseph II, 40, L-1840 Luxembourg, LuxembourgRed Cross of Luxemburg, Boulevard Joseph II, 40, L-1840 Luxembourg, LuxembourgIntegrated Biobank of Luxembourg, 1 rue Louis Rech, L-3555 Dudelange, LuxembourgIntegrated Biobank of Luxembourg, 1 rue Louis Rech, L-3555 Dudelange, LuxembourgIntegrated Biobank of Luxembourg, 1 rue Louis Rech, L-3555 Dudelange, LuxembourgRed Cross of Luxemburg, Boulevard Joseph II, 40, L-1840 Luxembourg, LuxembourgBackground and Objectives: Since 2015, platelet products have been pathogen-inactivated (PI) at the Luxemburgish Red Cross (LRC) using Riboflavin and UV light (RF-PI). As the LRC should respond to hospital needs at any time, platelet production exceeds the demand, generating a discard rate of 18%. To reduce this, we consider the extension of storage time from 5 to 7 days. This study’s objective was to evaluate the in vitro 7-day platelet-storage quality, comparing two PI technologies, RF-PI and amotosalen/UVA light (AM-PI), for platelet pools from whole-blood donations (PPCs) and apheresis platelets collected from single apheresis donation (APCs). Materials and Methods: For each product type, 6 double-platelet concentrates were prepared and divided into 2 units; one was treated with RF-PI and the other by AM-PI. In vitro platelet-quality parameters were tested pre- and post-PI, at days 5 and 7. Results: Treatment and storage lesions were observed in PPCs and APCs with both PI methods. We found a higher rate of lactate increase and glucose depletion, suggesting a stronger stimulation of the glycolytic pathway, a higher Annexin V binding, and a loss of swirling in the RF-PI-treated units from day 5. The platelet loss was significantly higher in the AM-PI compared with the RF-PI units. Conclusions: Results suggest that RF-PI treatment has a higher deleterious impact on in vitro platelet quality compared to AM-PI, but we observed higher loss of platelets with AM-PI due to the post-illumination amotosalen adsorption step. If 7-day storage is needed, it can only be achieved with AM-PI, based on our quality criteria.https://www.mdpi.com/2076-0817/11/3/3437-day platelet storagepathogen inactivationplatelet quality
spellingShingle Nicolas Malvaux
Fanette Defraigne
Styliani Bartziali
Camille Bellora
Kathleen Mommaerts
Fay Betsou
Anne Schuhmacher
In Vitro Comparative Study of Platelets Treated with Two Pathogen-Inactivation Methods to Extend Shelf Life to 7 Days
Pathogens
7-day platelet storage
pathogen inactivation
platelet quality
title In Vitro Comparative Study of Platelets Treated with Two Pathogen-Inactivation Methods to Extend Shelf Life to 7 Days
title_full In Vitro Comparative Study of Platelets Treated with Two Pathogen-Inactivation Methods to Extend Shelf Life to 7 Days
title_fullStr In Vitro Comparative Study of Platelets Treated with Two Pathogen-Inactivation Methods to Extend Shelf Life to 7 Days
title_full_unstemmed In Vitro Comparative Study of Platelets Treated with Two Pathogen-Inactivation Methods to Extend Shelf Life to 7 Days
title_short In Vitro Comparative Study of Platelets Treated with Two Pathogen-Inactivation Methods to Extend Shelf Life to 7 Days
title_sort in vitro comparative study of platelets treated with two pathogen inactivation methods to extend shelf life to 7 days
topic 7-day platelet storage
pathogen inactivation
platelet quality
url https://www.mdpi.com/2076-0817/11/3/343
work_keys_str_mv AT nicolasmalvaux invitrocomparativestudyofplateletstreatedwithtwopathogeninactivationmethodstoextendshelflifeto7days
AT fanettedefraigne invitrocomparativestudyofplateletstreatedwithtwopathogeninactivationmethodstoextendshelflifeto7days
AT stylianibartziali invitrocomparativestudyofplateletstreatedwithtwopathogeninactivationmethodstoextendshelflifeto7days
AT camillebellora invitrocomparativestudyofplateletstreatedwithtwopathogeninactivationmethodstoextendshelflifeto7days
AT kathleenmommaerts invitrocomparativestudyofplateletstreatedwithtwopathogeninactivationmethodstoextendshelflifeto7days
AT faybetsou invitrocomparativestudyofplateletstreatedwithtwopathogeninactivationmethodstoextendshelflifeto7days
AT anneschuhmacher invitrocomparativestudyofplateletstreatedwithtwopathogeninactivationmethodstoextendshelflifeto7days